ストックスクリーナーアプリを入手
219.26
0.53%
1.15
アフターアワーズ：
218.77
-0.49
-0.22%
Abbvie Inc (ABBV) 最新ニュース
Commerzbank Aktiengesellschaft FI Sells 39,586 Shares of AbbVie Inc. $ABBV - MarketBeat
Cullen Frost Bankers Inc. Has $88.49 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
West to Sell SmartDose 3.5mL System to AbbVie in $112.5M Deal - mychesco.com
AbbVie is a top dividend stock as drug pipelines drive payout hikes - thestreet.com
Mn Services Vermogensbeheer B.V. Has $155.25 Million Position in AbbVie Inc. $ABBV - MarketBeat
Resona Asset Management Co. Ltd. Decreases Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Sells 18,081 Shares of AbbVie Inc. $ABBV - MarketBeat
UniSuper Management Pty Ltd Has $58.21 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by Jennison Associates LLC - MarketBeat
Delta Financial Advisors LLC Purchases 4,830 Shares of AbbVie Inc. $ABBV - MarketBeat
TrueMark Investments LLC Lowers Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie stock rises as India rejects Venetoclax patent bid; ABBV traders eye Feb. 4 earnings - TechStock²
AbbVie Inc. $ABBV Shares Sold by Lockheed Martin Investment Management Co. - MarketBeat
Indian Patent Office rejects AbbVie patent bid for cancer drug Venetoclax; generics may enter market - domain-b.com
AbbVie Inc. $ABBV Shares Purchased by Strs Ohio - MarketBeat
AbbVie Dodged a Patent Disaster, and Shares Gained 460%. Merck and Bristol Myers Are Next. - Barron's
AbbVie stock rises as Wall Street rallies; traders eye Feb. 4 earnings and the Fed next week - TechStock²
ABBV vs. MRK: An Oncology-Immunology Showdown for Investors - Yahoo Finance
2 High-Yielding Dividend Stocks That Retirees Can Rely on for Recurring Income - Finviz
March 6th Options Now Available For AbbVie (ABBV) - Nasdaq
Analysts’ Opinions Are Mixed on These Healthcare Stocks: AbbVie (ABBV) and Acadia Healthcare (ACHC) - The Globe and Mail
AbbVie Inc. $ABBV Shares Sold by Simplicity Wealth LLC - MarketBeat
AbbVie Inc. (NYSE:ABBV) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
RemeGen scores out-licensing triple play with AbbVie deal - thebambooworks.com
Bernstein Sticks to Their Hold Rating for AbbVie (ABBV) - The Globe and Mail
AbbVie stock rises after-hours as Bernstein sticks with $225 target ahead of Feb. 4 earnings - TechStock²
AbbVie stock edges higher as Berenberg lifts target; tariffs and Feb. 4 earnings in play - TechStock²
Price Over Earnings Overview: AbbVieAbbVie (NYSE:ABBV) - Benzinga
Johnson & Johnson Clears the Patent Cliff as 2026 Guidance Resets the Narrative - Investing.com
Giant-Cell Arteritis Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | AbbVie, Novartis, CSL, Kiniksa Pharma, Eli Lilly, Roche, Johnson & Johnson, MorphoSys AG - Barchart.com
Biocom Announces Powerhouse Keynote Panel Featuring Heads of Discovery and Research & Development from AbbVie, Amgen and Eli Lilly at 2026 Global Partnering & Investor Conference - Morningstar
208,510 Shares in AbbVie Inc. $ABBV Purchased by Rakuten Investment Management Inc. - MarketBeat
Vest Financial LLC Has $72.41 Million Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by Migdal Insurance & Financial Holdings Ltd. - MarketBeat
AbbVie (ABBV) Looks to Deepen Its Push Into Rapidly Growing Obesity-Treatment Market - Finviz
AbbVie price pierces main upward trend lineForecast today21-01-2026 - Economies.com
Bailard Inc. Acquires 16,049 Shares of AbbVie Inc. $ABBV - MarketBeat
Analysts Are Bullish on Top Healthcare Stocks: Dexcom (DXCM), AbbVie (ABBV) - The Globe and Mail
Lobbying Update: $1,330,000 of ABBVIE INC. lobbying was just disclosed - Quiver Quantitative
AbbVie Inc.: How a Pharma Powerhouse Turned an Aging Blockbuster Into a Next-Gen Pipeline Machine - AD HOC NEWS
AbbVie stock slips as traders watch Epkinly data and the next earnings clock - TechStock²
Bernstein reiterates Market Perform rating on Abbvie stock at $225 target - Investing.com
Triasima Portfolio Management inc. Invests $2.80 Million in AbbVie Inc. $ABBV - MarketBeat
Vaughan David Investments LLC IL Has $77.91 Million Stake in AbbVie Inc. $ABBV - MarketBeat
Dynasty Wealth Management LLC Takes Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie price target raised to $275 from $270 at Berenberg - TipRanks
AbbVie Inc. $ABBV Shares Purchased by Arkadios Wealth Advisors - MarketBeat
Parkinson’s Disease Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | AbbVie, Pfizer, Novartis, F. Roche, Kissei Pharma, AstraZeneca, Prevail - Barchart.com
The 3 Most Reliable Dividend Stocks to Buy for Years to Come - Yahoo Finance
Understanding Momentum Shifts in (ABBV) - Stock Traders Daily
Assessing AbbVie (ABBV) Valuation After Recent Share Price Pullback - Yahoo Finance
AbbVie stock price: ABBV heads into Tuesday with epcoritamab trial in the crosshairs - TechStock²
The Best Healthcare Stocks to Buy With $5,000 in 2026 and Hold Forever - Finviz
In Brief: AbbVie/Genmab’s Epkinly Phase III In DLBCL Falls Short On Survival Endpoint - Citeline News & Insights
How Do Investors Really Feel About AbbVie Inc? - Benzinga
AbbVie, Genmab’s Bispecific Misses Key Overall Survival Endpoint in Phase III Lymphoma Study - BioSpace
Tradewinds LLC. Purchases New Shares in AbbVie Inc. $ABBV - MarketBeat
Violich Capital Management Inc. Grows Position in AbbVie Inc. $ABBV - MarketBeat
Wealth Enhancement Advisory Services LLC Increases Holdings in AbbVie Inc. $ABBV - MarketBeat
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever - Finviz
Campbell & CO Investment Adviser LLC Buys Shares of 5,480 AbbVie Inc. $ABBV - MarketBeat
Axecap Investments LLC Sells 25,567 Shares of AbbVie Inc. $ABBV - MarketBeat
Allstate Corp Has $14.87 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
The Smartest Dividend Stocks to Buy in 2026 With $1,000 Right Now -- Including Realty Income and AbbVie - The Globe and Mail
FY2025 Earnings Forecast for AbbVie Issued By Zacks Research - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Massachusetts Financial Services Co. MA - MarketBeat
8,604 Shares in AbbVie Inc. $ABBV Bought by Tred Avon Family Wealth LLC - MarketBeat
Rep. Julie Johnson Sells Off Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Could Buying This Stock Today Pay Off Big Over the Next 5 Years? - Finviz
1.48%
0.92%
大文字化:
|
ボリューム (24 時間):